Search

Your search keyword '"Daniel J. Dooley"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Daniel J. Dooley" Remove constraint Author: "Daniel J. Dooley"
24 results on '"Daniel J. Dooley"'

Search Results

1. Length of stay and readmission in older adults hospitalized for heart failure

2. One- to 10-Day Versus 11- to 30-Day All-Cause Readmission and Mortality in Older Patients With Heart Failure

3. Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate

4. Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers

5. Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial

6. Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial

7. Abstract 21189: High Diastolic Blood Pressure (DBP) and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) and Hypertension (HTN): Findings From Medicare-Linked OPTIMIZE-HF Registry

8. Abstract 21191: Low Diastolic Blood Pressure (DBP) and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) and Hypertension (HTN): Findings From Medicare-Linked OPTIMIZE-HF Registry

9. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction

10. The Role of Positive Inotropic Drugs in the Treatment of Older Adults with Heart Failure and Reduced Ejection Fraction

11. Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study

12. Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone

13. HIGH-DOSE BETA-BLOCKERS (BB) AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (HFPEF) AND HEART RATE ≥70 BEATS PER MINUTE (BPM)

14. SECONDHAND SMOKE IS LINKED TO HIGHER RISK OF NON-CARDIOVASCULAR MORTALITY BUT NOT OF CARDIOVASCULAR MORTALITY IN COMMUNITY-DWELLING OLDER ADULTS: FINDINGS FROM CARDIOVASCULAR HEALTH STUDY (CHS)

15. Corrigendum to 'Systolic–diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study' [Int. J. Cardiol. 235 (2017) 11–16]

16. ORTHOPNEA OR PAROXYSMAL NOCTURNAL DYSPNEA IN OLDER ADULTS WITHOUT PREVALENT HEART FAILURE IS A PREDICTOR, BUT NOT AN INDEPENDENT RISK FACTOR FOR INCIDENT HEART FAILURE: INSIGHTS FROM THE CARDIOVASCULAR HEALTH STUDY

17. AMONG OLDER HEART FAILURE (HF) PATIENTS WITH IN-HOSPITAL ACUTE KIDNEY INJURY (AKI), AN IMPROVEMENT IN KIDNEY FUNCTION IS ASSOCIATED WITH A HIGHER RISK OF POST-DISCHARGE MORTALITY BUT NOT READMISSION

18. CLINICAL EFFECTIVENESS OF SPIRONOLACTONE IN HOSPITALIZED OLDER ELIGIBLE (EF LESS THAN OR EQUAL TO 35% AND EGFR GREATER THAN OR EQUAL TO 30 ML/MIN/1.73 M2) PATIENTS WITH HEART FAILURE

19. ADVERSE OUTCOMES WITH USE OF HYDRALAZINE AND NITRATE COMBINATION THERAPY IN HOSPITALIZED OLDER NON-BLACK PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION (HFREF)

20. CHRONIC ALPHA BLOCKER USE AND OUTCOMES IN OLDER MALE MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE

21. HEART FAILURE HOSPITALIZATION (HFH) DESPITE DIGOXIN THERAPY VERSUS NO HFH DESPITE PLACEBO IN THE DIGITALIS INVESTIGATION GROUP (DIG) TRIAL: INSIGHTS INTO RISK FACTORS FOR HFH IN HF AND REDUCED EJECTION FRACTION (HFREF)

22. A randomized pilot study on the effect of niacin on pulmonary arterial pressure

23. CRT-504 A Pilot Study of the Effect of Niacin on Pulmonary Arterial Pressure

24. Operator volumes and salvage index in AMI

Catalog

Books, media, physical & digital resources